文献速递神经康复

COVID-19重症多发性神经病与功能结局:四例报告及范围综述

Critical Illness Polyneuropathy and Functional Outcome in Subjects with Covid-19: Report on Four Patients and a Scoping Review of the Literature.
PubMed 文献 · J Rehabil Med · 2022-04-07

本文报告4例COVID-19后ICU获得性无力患者(3男1女,平均年龄59.2±8.62岁),经肌电图诊断,其中3例为危重病多发性神经病,1例为危重病多发性神经病/肌病,随访时3例完全恢复,1例遗留中度残疾。范围综述纳入11项研究共80例COVID-19合并ICU获得性无力患者,35例存活者中仅3例(8.5%)完全恢复。

要点

  • COVID-19患者可发生ICU获得性无力,肌电图可区分危重病多发性神经病与肌病。
  • 4例中3例危重病多发性神经病随访完全恢复,1例合并肌病者遗留中度残疾。
  • 范围综述35例存活者仅3例(8.5%)完全恢复,均为危重病肌病。

核心结论

  • ICU获得性无力在COVID-19患者中常见,恢复程度不一,完全恢复比例低。
  • 研究异质性大,无法得出确定性结论。

研究设计与样本

  • 病例系列报告4例COVID-19后ICU获得性无力患者,并附范围综述。
  • 4例中3男1女,平均年龄59.2±8.62岁,经肌电图诊断。
  • 范围综述检索到11项研究,共80例COVID-19合并ICU获得性无力患者。

主要发现

  • 4例中3例为危重病多发性神经病,1例为危重病多发性神经病/肌病。
  • 随访时3例危重病多发性神经病患者完全恢复。
  • 1例危重病多发性神经病/肌病患者遗留中度残疾,需双侧踝足矫形器及行走支持。
  • 范围综述80例中,23例危重病肌病(7例 probable)、21例危重病多发性神经病(8例 possible)、15例危重病多发性神经病和肌病、21例ICU获得性无力。
  • 35例存活者中仅3例(8.5%)完全恢复,均为危重病肌病(其中2例为 probable 危重病肌病)。

关键数值与推荐

  • 肌电图诊断:3例危重病多发性神经病,1例危重病多发性神经病/肌病。
  • 评估工具:医学研究委员会肌力评分、残疾评定量表、功能独立性评定,于入院、出院及出院后6个月随访时进行。
  • 范围综述存活者完全恢复比例:3/35(8.5%)。

临床怎么用

  • 对COVID-19后ICU获得性无力患者应行肌电图检查以明确神经病或肌病类型。
  • 康复评估应包含肌力、残疾和功能独立性,并关注出院后6个月随访。
  • 合并危重病多发性神经病/肌病患者可能需踝足矫形器等辅助器具支持行走。

局限性

  • 病例数少(4例),范围综述研究异质性大,无法得出确定性结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with COVID-19 may develop a range of neurological disorders. We report here 4 COVID-19 subjects with intensive care unit-acquired weakness and their functional outcome. In addition, a scoping review of COVID-19 literature was performed to investigate this issue. Of the post-COVID-19 patients admitted to our Neuro-Rehabilitation Unit, 4 (3 males, 1 female; mean age 59.2 ± 8.62 years) had intensive care unit-acquired weakness, diagnosed with electromyography. Muscle strength and functional evaluation were performed on all patients with Medical Research Council, Disability Rating Scale and Functional Independence Measure, respectively, at admission, discharge and 6-month follow-up after discharge. Electromyography revealed that 3 subjects had critical illness polyneuropathy and 1 had critical illness polyneuropathy/critical illness myopathy. At follow-up, the 3 subjects with critical illness polyneuropathy reached full recovery. The patient with critical illness polyneuropathy/critical illness myopathy showed moderate disability requiring bilateral ankle foot-orthosis and support for ambulation. The scoping review retrieved 11 studies of COVID-19 patients with intensive care unit-acquired weakness, concerning a total of 80 patients: 23 with critical illness myopathy (7 probable), 21 with critical illness polyneuropathy (8 possible), 15 with critical illness polyneuropathy and myopathy (CIPNM) and 21 with intensive care unit-acquired weakness. Of 35 patients who survived, only 3 (8.5%) reached full recovery. All 3 had critical illness myopathy, but 2 of these had a diagnosis of probable critical illness myopathy. Intensive care unit-acquired weakness commonly occurred in subjects with COVID-19. Recovery was variable and a low percentage reached full recovery. However, the heterogeneity of studies did not allow definitive conclusions to be drawn.

来源:J Rehabil Med,查看原文。版权归原作者所有。

引用

  1. Intiso D, Marco Centra A, Giordano A, et al. Critical Illness Polyneuropathy and Functional Outcome in Subjects with Covid-19: Report on Four Patients and a Scoping Review of the Literature. J Rehabil Med. 2022. PMID: 34935988. doi:10.2340/jrm.v53.1139

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。